Global Cancer Drug Therapy Market Insights and Forecast to 2031

Report ID: 1197275 | Published Date: Jan 2025 | No. of Page: 116 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Cancer Drug Therapy Product Introduction
    1.2 Market by Type
        1.2.1 Global Cancer Drug Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Targeted Therapy
        1.2.3 Chemotherapy
        1.2.4 Immunotherapy
    1.3 Market by Application
        1.3.1 Global Cancer Drug Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Angiogenesis Inhibitors
        1.3.3 mTOR Inhibitors
        1.3.4 Monoclonal Antibodies
        1.3.5 Cytokine Immunotherapy (IL-2)
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Cancer Drug Therapy Sales Estimates and Forecasts 2017-2028
    2.2 Global Cancer Drug Therapy Revenue Estimates and Forecasts 2017-2028
    2.3 Global Cancer Drug Therapy Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Cancer Drug Therapy Sales by Region
        2.4.1 Global Cancer Drug Therapy Sales by Region (2017-2022)
        2.4.2 Global Sales Cancer Drug Therapy by Region (2023-2028)
    2.5 Global Cancer Drug Therapy Revenue by Region
        2.5.1 Global Cancer Drug Therapy Revenue by Region (2017-2022)
        2.5.2 Global Cancer Drug Therapy Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Cancer Drug Therapy Sales by Manufacturers
        3.1.1 Global Top Cancer Drug Therapy Manufacturers by Sales (2017-2022)
        3.1.2 Global Cancer Drug Therapy Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Cancer Drug Therapy in 2021
    3.2 Global Cancer Drug Therapy Revenue by Manufacturers
        3.2.1 Global Cancer Drug Therapy Revenue by Manufacturers (2017-2022)
        3.2.2 Global Cancer Drug Therapy Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Cancer Drug Therapy Revenue in 2021
    3.3 Global Cancer Drug Therapy Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Cancer Drug Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Cancer Drug Therapy Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Cancer Drug Therapy Sales by Type
        4.1.1 Global Cancer Drug Therapy Historical Sales by Type (2017-2022)
        4.1.2 Global Cancer Drug Therapy Forecasted Sales by Type (2023-2028)
        4.1.3 Global Cancer Drug Therapy Sales Market Share by Type (2017-2028)
    4.2 Global Cancer Drug Therapy Revenue by Type
        4.2.1 Global Cancer Drug Therapy Historical Revenue by Type (2017-2022)
        4.2.2 Global Cancer Drug Therapy Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Cancer Drug Therapy Revenue Market Share by Type (2017-2028)
    4.3 Global Cancer Drug Therapy Price by Type
        4.3.1 Global Cancer Drug Therapy Price by Type (2017-2022)
        4.3.2 Global Cancer Drug Therapy Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Cancer Drug Therapy Sales by Application
        5.1.1 Global Cancer Drug Therapy Historical Sales by Application (2017-2022)
        5.1.2 Global Cancer Drug Therapy Forecasted Sales by Application (2023-2028)
        5.1.3 Global Cancer Drug Therapy Sales Market Share by Application (2017-2028)
    5.2 Global Cancer Drug Therapy Revenue by Application
        5.2.1 Global Cancer Drug Therapy Historical Revenue by Application (2017-2022)
        5.2.2 Global Cancer Drug Therapy Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Cancer Drug Therapy Revenue Market Share by Application (2017-2028)
    5.3 Global Cancer Drug Therapy Price by Application
        5.3.1 Global Cancer Drug Therapy Price by Application (2017-2022)
        5.3.2 Global Cancer Drug Therapy Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Cancer Drug Therapy Market Size by Type
        6.1.1 North America Cancer Drug Therapy Sales by Type (2017-2028)
        6.1.2 North America Cancer Drug Therapy Revenue by Type (2017-2028)
    6.2 North America Cancer Drug Therapy Market Size by Application
        6.2.1 North America Cancer Drug Therapy Sales by Application (2017-2028)
        6.2.2 North America Cancer Drug Therapy Revenue by Application (2017-2028)
    6.3 North America Cancer Drug Therapy Market Size by Country
        6.3.1 North America Cancer Drug Therapy Sales by Country (2017-2028)
        6.3.2 North America Cancer Drug Therapy Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Cancer Drug Therapy Market Size by Type
        7.1.1 Europe Cancer Drug Therapy Sales by Type (2017-2028)
        7.1.2 Europe Cancer Drug Therapy Revenue by Type (2017-2028)
    7.2 Europe Cancer Drug Therapy Market Size by Application
        7.2.1 Europe Cancer Drug Therapy Sales by Application (2017-2028)
        7.2.2 Europe Cancer Drug Therapy Revenue by Application (2017-2028)
    7.3 Europe Cancer Drug Therapy Market Size by Country
        7.3.1 Europe Cancer Drug Therapy Sales by Country (2017-2028)
        7.3.2 Europe Cancer Drug Therapy Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Cancer Drug Therapy Market Size by Type
        8.1.1 Asia Pacific Cancer Drug Therapy Sales by Type (2017-2028)
        8.1.2 Asia Pacific Cancer Drug Therapy Revenue by Type (2017-2028)
    8.2 Asia Pacific Cancer Drug Therapy Market Size by Application
        8.2.1 Asia Pacific Cancer Drug Therapy Sales by Application (2017-2028)
        8.2.2 Asia Pacific Cancer Drug Therapy Revenue by Application (2017-2028)
    8.3 Asia Pacific Cancer Drug Therapy Market Size by Region
        8.3.1 Asia Pacific Cancer Drug Therapy Sales by Region (2017-2028)
        8.3.2 Asia Pacific Cancer Drug Therapy Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Cancer Drug Therapy Market Size by Type
        9.1.1 Latin America Cancer Drug Therapy Sales by Type (2017-2028)
        9.1.2 Latin America Cancer Drug Therapy Revenue by Type (2017-2028)
    9.2 Latin America Cancer Drug Therapy Market Size by Application
        9.2.1 Latin America Cancer Drug Therapy Sales by Application (2017-2028)
        9.2.2 Latin America Cancer Drug Therapy Revenue by Application (2017-2028)
    9.3 Latin America Cancer Drug Therapy Market Size by Country
        9.3.1 Latin America Cancer Drug Therapy Sales by Country (2017-2028)
        9.3.2 Latin America Cancer Drug Therapy Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Cancer Drug Therapy Market Size by Type
        10.1.1 Middle East and Africa Cancer Drug Therapy Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Cancer Drug Therapy Revenue by Type (2017-2028)
    10.2 Middle East and Africa Cancer Drug Therapy Market Size by Application
        10.2.1 Middle East and Africa Cancer Drug Therapy Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Cancer Drug Therapy Revenue by Application (2017-2028)
    10.3 Middle East and Africa Cancer Drug Therapy Market Size by Country
        10.3.1 Middle East and Africa Cancer Drug Therapy Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Cancer Drug Therapy Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Amgen / Allergan
        11.1.1 Amgen / Allergan Corporation Information
        11.1.2 Amgen / Allergan Overview
        11.1.3 Amgen / Allergan Cancer Drug Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Amgen / Allergan Cancer Drug Therapy Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Amgen / Allergan Recent Developments
    11.2 Argos Therapeutics
        11.2.1 Argos Therapeutics Corporation Information
        11.2.2 Argos Therapeutics Overview
        11.2.3 Argos Therapeutics Cancer Drug Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Argos Therapeutics Cancer Drug Therapy Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Argos Therapeutics Recent Developments
    11.3 AstraZeneca
        11.3.1 AstraZeneca Corporation Information
        11.3.2 AstraZeneca Overview
        11.3.3 AstraZeneca Cancer Drug Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 AstraZeneca Cancer Drug Therapy Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 AstraZeneca Recent Developments
    11.4 Aveo Pharmaceuticals
        11.4.1 Aveo Pharmaceuticals Corporation Information
        11.4.2 Aveo Pharmaceuticals Overview
        11.4.3 Aveo Pharmaceuticals Cancer Drug Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Aveo Pharmaceuticals Cancer Drug Therapy Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Aveo Pharmaceuticals Recent Developments
    11.5 Bayer
        11.5.1 Bayer Corporation Information
        11.5.2 Bayer Overview
        11.5.3 Bayer Cancer Drug Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Bayer Cancer Drug Therapy Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Bayer Recent Developments
    11.6 Exelixis
        11.6.1 Exelixis Corporation Information
        11.6.2 Exelixis Overview
        11.6.3 Exelixis Cancer Drug Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Exelixis Cancer Drug Therapy Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Exelixis Recent Developments
    11.7 Incyte
        11.7.1 Incyte Corporation Information
        11.7.2 Incyte Overview
        11.7.3 Incyte Cancer Drug Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Incyte Cancer Drug Therapy Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Incyte Recent Developments
    11.8 Merck
        11.8.1 Merck Corporation Information
        11.8.2 Merck Overview
        11.8.3 Merck Cancer Drug Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Merck Cancer Drug Therapy Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Merck Recent Developments
    11.9 Roche
        11.9.1 Roche Corporation Information
        11.9.2 Roche Overview
        11.9.3 Roche Cancer Drug Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Roche Cancer Drug Therapy Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Roche Recent Developments
    11.10 Bristol-Myers Squibb
        11.10.1 Bristol-Myers Squibb Corporation Information
        11.10.2 Bristol-Myers Squibb Overview
        11.10.3 Bristol-Myers Squibb Cancer Drug Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Bristol-Myers Squibb Cancer Drug Therapy Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Bristol-Myers Squibb Recent Developments
    11.11 Eisai
        11.11.1 Eisai Corporation Information
        11.11.2 Eisai Overview
        11.11.3 Eisai Cancer Drug Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Eisai Cancer Drug Therapy Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Eisai Recent Developments
    11.12 Exelixis
        11.12.1 Exelixis Corporation Information
        11.12.2 Exelixis Overview
        11.12.3 Exelixis Cancer Drug Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 Exelixis Cancer Drug Therapy Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Exelixis Recent Developments
    11.13 Genentech (Roche)
        11.13.1 Genentech (Roche) Corporation Information
        11.13.2 Genentech (Roche) Overview
        11.13.3 Genentech (Roche) Cancer Drug Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
        11.13.4 Genentech (Roche) Cancer Drug Therapy Product Model Numbers, Pictures, Descriptions and Specifications
        11.13.5 Genentech (Roche) Recent Developments
    11.14 Novartis
        11.14.1 Novartis Corporation Information
        11.14.2 Novartis Overview
        11.14.3 Novartis Cancer Drug Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
        11.14.4 Novartis Cancer Drug Therapy Product Model Numbers, Pictures, Descriptions and Specifications
        11.14.5 Novartis Recent Developments
    11.15 Pfizer
        11.15.1 Pfizer Corporation Information
        11.15.2 Pfizer Overview
        11.15.3 Pfizer Cancer Drug Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
        11.15.4 Pfizer Cancer Drug Therapy Product Model Numbers, Pictures, Descriptions and Specifications
        11.15.5 Pfizer Recent Developments
    11.16 Prometheus Labs
        11.16.1 Prometheus Labs Corporation Information
        11.16.2 Prometheus Labs Overview
        11.16.3 Prometheus Labs Cancer Drug Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
        11.16.4 Prometheus Labs Cancer Drug Therapy Product Model Numbers, Pictures, Descriptions and Specifications
        11.16.5 Prometheus Labs Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Cancer Drug Therapy Industry Chain Analysis
    12.2 Cancer Drug Therapy Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Cancer Drug Therapy Production Mode & Process
    12.4 Cancer Drug Therapy Sales and Marketing
        12.4.1 Cancer Drug Therapy Sales Channels
        12.4.2 Cancer Drug Therapy Distributors
    12.5 Cancer Drug Therapy Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Cancer Drug Therapy Industry Trends
    13.2 Cancer Drug Therapy Market Drivers
    13.3 Cancer Drug Therapy Market Challenges
    13.4 Cancer Drug Therapy Market Restraints
14 Key Findings in The Global Cancer Drug Therapy Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Cancer Drug Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Targeted Therapy
    Table 3. Major Manufacturers of Chemotherapy
    Table 4. Major Manufacturers of Immunotherapy
    Table 5. Global Cancer Drug Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Cancer Drug Therapy Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Cancer Drug Therapy Sales by Region (2017-2022) & (K Units)
    Table 8. Global Cancer Drug Therapy Sales Market Share by Region (2017-2022)
    Table 9. Global Cancer Drug Therapy Sales by Region (2023-2028) & (K Units)
    Table 10. Global Cancer Drug Therapy Sales Market Share by Region (2023-2028)
    Table 11. Global Cancer Drug Therapy Revenue by Region (2017-2022) & (US$ Million)
    Table 12. Global Cancer Drug Therapy Revenue Market Share by Region (2017-2022)
    Table 13. Global Cancer Drug Therapy Revenue by Region (2023-2028) & (US$ Million)
    Table 14. Global Cancer Drug Therapy Revenue Market Share by Region (2023-2028)
    Table 15. Global Cancer Drug Therapy Sales by Manufacturers (2017-2022) & (K Units)
    Table 16. Global Cancer Drug Therapy Sales Share by Manufacturers (2017-2022)
    Table 17. Global Cancer Drug Therapy Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 18. Global Cancer Drug Therapy Revenue Share by Manufacturers (2017-2022)
    Table 19. Cancer Drug Therapy Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 20. Global Cancer Drug Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global Cancer Drug Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Drug Therapy as of 2021)
    Table 22. Cancer Drug Therapy Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Cancer Drug Therapy Product Offered
    Table 24. Date of Manufacturers Enter into Cancer Drug Therapy Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Cancer Drug Therapy Sales by Type (2017-2022) & (K Units)
    Table 27. Global Cancer Drug Therapy Sales by Type (2023-2028) & (K Units)
    Table 28. Global Cancer Drug Therapy Sales Share by Type (2017-2022)
    Table 29. Global Cancer Drug Therapy Sales Share by Type (2023-2028)
    Table 30. Global Cancer Drug Therapy Revenue by Type (2017-2022) & (US$ Million)
    Table 31. Global Cancer Drug Therapy Revenue by Type (2023-2028) & (US$ Million)
    Table 32. Global Cancer Drug Therapy Revenue Share by Type (2017-2022)
    Table 33. Global Cancer Drug Therapy Revenue Share by Type (2023-2028)
    Table 34. Cancer Drug Therapy Price by Type (2017-2022) & (USD/Unit)
    Table 35. Global Cancer Drug Therapy Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 36. Global Cancer Drug Therapy Sales by Application (2017-2022) & (K Units)
    Table 37. Global Cancer Drug Therapy Sales by Application (2023-2028) & (K Units)
    Table 38. Global Cancer Drug Therapy Sales Share by Application (2017-2022)
    Table 39. Global Cancer Drug Therapy Sales Share by Application (2023-2028)
    Table 40. Global Cancer Drug Therapy Revenue by Application (2017-2022) & (US$ Million)
    Table 41. Global Cancer Drug Therapy Revenue by Application (2023-2028) & (US$ Million)
    Table 42. Global Cancer Drug Therapy Revenue Share by Application (2017-2022)
    Table 43. Global Cancer Drug Therapy Revenue Share by Application (2023-2028)
    Table 44. Cancer Drug Therapy Price by Application (2017-2022) & (USD/Unit)
    Table 45. Global Cancer Drug Therapy Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 46. North America Cancer Drug Therapy Sales by Type (2017-2022) & (K Units)
    Table 47. North America Cancer Drug Therapy Sales by Type (2023-2028) & (K Units)
    Table 48. North America Cancer Drug Therapy Revenue by Type (2017-2022) & (US$ Million)
    Table 49. North America Cancer Drug Therapy Revenue by Type (2023-2028) & (US$ Million)
    Table 50. North America Cancer Drug Therapy Sales by Application (2017-2022) & (K Units)
    Table 51. North America Cancer Drug Therapy Sales by Application (2023-2028) & (K Units)
    Table 52. North America Cancer Drug Therapy Revenue by Application (2017-2022) & (US$ Million)
    Table 53. North America Cancer Drug Therapy Revenue by Application (2023-2028) & (US$ Million)
    Table 54. North America Cancer Drug Therapy Sales by Country (2017-2022) & (K Units)
    Table 55. North America Cancer Drug Therapy Sales by Country (2023-2028) & (K Units)
    Table 56. North America Cancer Drug Therapy Revenue by Country (2017-2022) & (US$ Million)
    Table 57. North America Cancer Drug Therapy Revenue by Country (2023-2028) & (US$ Million)
    Table 58. Europe Cancer Drug Therapy Sales by Type (2017-2022) & (K Units)
    Table 59. Europe Cancer Drug Therapy Sales by Type (2023-2028) & (K Units)
    Table 60. Europe Cancer Drug Therapy Revenue by Type (2017-2022) & (US$ Million)
    Table 61. Europe Cancer Drug Therapy Revenue by Type (2023-2028) & (US$ Million)
    Table 62. Europe Cancer Drug Therapy Sales by Application (2017-2022) & (K Units)
    Table 63. Europe Cancer Drug Therapy Sales by Application (2023-2028) & (K Units)
    Table 64. Europe Cancer Drug Therapy Revenue by Application (2017-2022) & (US$ Million)
    Table 65. Europe Cancer Drug Therapy Revenue by Application (2023-2028) & (US$ Million)
    Table 66. Europe Cancer Drug Therapy Sales by Country (2017-2022) & (K Units)
    Table 67. Europe Cancer Drug Therapy Sales by Country (2023-2028) & (K Units)
    Table 68. Europe Cancer Drug Therapy Revenue by Country (2017-2022) & (US$ Million)
    Table 69. Europe Cancer Drug Therapy Revenue by Country (2023-2028) & (US$ Million)
    Table 70. Asia Pacific Cancer Drug Therapy Sales by Type (2017-2022) & (K Units)
    Table 71. Asia Pacific Cancer Drug Therapy Sales by Type (2023-2028) & (K Units)
    Table 72. Asia Pacific Cancer Drug Therapy Revenue by Type (2017-2022) & (US$ Million)
    Table 73. Asia Pacific Cancer Drug Therapy Revenue by Type (2023-2028) & (US$ Million)
    Table 74. Asia Pacific Cancer Drug Therapy Sales by Application (2017-2022) & (K Units)
    Table 75. Asia Pacific Cancer Drug Therapy Sales by Application (2023-2028) & (K Units)
    Table 76. Asia Pacific Cancer Drug Therapy Revenue by Application (2017-2022) & (US$ Million)
    Table 77. Asia Pacific Cancer Drug Therapy Revenue by Application (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Cancer Drug Therapy Sales by Region (2017-2022) & (K Units)
    Table 79. Asia Pacific Cancer Drug Therapy Sales by Region (2023-2028) & (K Units)
    Table 80. Asia Pacific Cancer Drug Therapy Revenue by Region (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Cancer Drug Therapy Revenue by Region (2023-2028) & (US$ Million)
    Table 82. Latin America Cancer Drug Therapy Sales by Type (2017-2022) & (K Units)
    Table 83. Latin America Cancer Drug Therapy Sales by Type (2023-2028) & (K Units)
    Table 84. Latin America Cancer Drug Therapy Revenue by Type (2017-2022) & (US$ Million)
    Table 85. Latin America Cancer Drug Therapy Revenue by Type (2023-2028) & (US$ Million)
    Table 86. Latin America Cancer Drug Therapy Sales by Application (2017-2022) & (K Units)
    Table 87. Latin America Cancer Drug Therapy Sales by Application (2023-2028) & (K Units)
    Table 88. Latin America Cancer Drug Therapy Revenue by Application (2017-2022) & (US$ Million)
    Table 89. Latin America Cancer Drug Therapy Revenue by Application (2023-2028) & (US$ Million)
    Table 90. Latin America Cancer Drug Therapy Sales by Country (2017-2022) & (K Units)
    Table 91. Latin America Cancer Drug Therapy Sales by Country (2023-2028) & (K Units)
    Table 92. Latin America Cancer Drug Therapy Revenue by Country (2017-2022) & (US$ Million)
    Table 93. Latin America Cancer Drug Therapy Revenue by Country (2023-2028) & (US$ Million)
    Table 94. Middle East and Africa Cancer Drug Therapy Sales by Type (2017-2022) & (K Units)
    Table 95. Middle East and Africa Cancer Drug Therapy Sales by Type (2023-2028) & (K Units)
    Table 96. Middle East and Africa Cancer Drug Therapy Revenue by Type (2017-2022) & (US$ Million)
    Table 97. Middle East and Africa Cancer Drug Therapy Revenue by Type (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa Cancer Drug Therapy Sales by Application (2017-2022) & (K Units)
    Table 99. Middle East and Africa Cancer Drug Therapy Sales by Application (2023-2028) & (K Units)
    Table 100. Middle East and Africa Cancer Drug Therapy Revenue by Application (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa Cancer Drug Therapy Revenue by Application (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Cancer Drug Therapy Sales by Country (2017-2022) & (K Units)
    Table 103. Middle East and Africa Cancer Drug Therapy Sales by Country (2023-2028) & (K Units)
    Table 104. Middle East and Africa Cancer Drug Therapy Revenue by Country (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Cancer Drug Therapy Revenue by Country (2023-2028) & (US$ Million)
    Table 106. Amgen / Allergan Corporation Information
    Table 107. Amgen / Allergan Description and Major Businesses
    Table 108. Amgen / Allergan Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 109. Amgen / Allergan Cancer Drug Therapy Product Model Numbers, Pictures, Descriptions and Specifications
    Table 110. Amgen / Allergan Recent Developments
    Table 111. Argos Therapeutics Corporation Information
    Table 112. Argos Therapeutics Description and Major Businesses
    Table 113. Argos Therapeutics Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 114. Argos Therapeutics Cancer Drug Therapy Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. Argos Therapeutics Recent Developments
    Table 116. AstraZeneca Corporation Information
    Table 117. AstraZeneca Description and Major Businesses
    Table 118. AstraZeneca Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 119. AstraZeneca Cancer Drug Therapy Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. AstraZeneca Recent Developments
    Table 121. Aveo Pharmaceuticals Corporation Information
    Table 122. Aveo Pharmaceuticals Description and Major Businesses
    Table 123. Aveo Pharmaceuticals Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 124. Aveo Pharmaceuticals Cancer Drug Therapy Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. Aveo Pharmaceuticals Recent Developments
    Table 126. Bayer Corporation Information
    Table 127. Bayer Description and Major Businesses
    Table 128. Bayer Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 129. Bayer Cancer Drug Therapy Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. Bayer Recent Developments
    Table 131. Exelixis Corporation Information
    Table 132. Exelixis Description and Major Businesses
    Table 133. Exelixis Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 134. Exelixis Cancer Drug Therapy Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. Exelixis Recent Developments
    Table 136. Incyte Corporation Information
    Table 137. Incyte Description and Major Businesses
    Table 138. Incyte Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 139. Incyte Cancer Drug Therapy Product Model Numbers, Pictures, Descriptions and Specifications
    Table 140. Incyte Recent Developments
    Table 141. Merck Corporation Information
    Table 142. Merck Description and Major Businesses
    Table 143. Merck Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 144. Merck Cancer Drug Therapy Product Model Numbers, Pictures, Descriptions and Specifications
    Table 145. Merck Recent Developments
    Table 146. Roche Corporation Information
    Table 147. Roche Description and Major Businesses
    Table 148. Roche Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 149. Roche Cancer Drug Therapy Product Model Numbers, Pictures, Descriptions and Specifications
    Table 150. Roche Recent Developments
    Table 151. Bristol-Myers Squibb Corporation Information
    Table 152. Bristol-Myers Squibb Description and Major Businesses
    Table 153. Bristol-Myers Squibb Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 154. Bristol-Myers Squibb Cancer Drug Therapy Product Model Numbers, Pictures, Descriptions and Specifications
    Table 155. Bristol-Myers Squibb Recent Developments
    Table 156. Eisai Corporation Information
    Table 157. Eisai Description and Major Businesses
    Table 158. Eisai Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 159. Eisai Cancer Drug Therapy Product Model Numbers, Pictures, Descriptions and Specifications
    Table 160. Eisai Recent Developments
    Table 161. Exelixis Corporation Information
    Table 162. Exelixis Description and Major Businesses
    Table 163. Exelixis Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 164. Exelixis Cancer Drug Therapy Product Model Numbers, Pictures, Descriptions and Specifications
    Table 165. Exelixis Recent Developments
    Table 166. Genentech (Roche) Corporation Information
    Table 167. Genentech (Roche) Description and Major Businesses
    Table 168. Genentech (Roche) Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 169. Genentech (Roche) Cancer Drug Therapy Product Model Numbers, Pictures, Descriptions and Specifications
    Table 170. Genentech (Roche) Recent Developments
    Table 171. Novartis Corporation Information
    Table 172. Novartis Description and Major Businesses
    Table 173. Novartis Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 174. Novartis Cancer Drug Therapy Product Model Numbers, Pictures, Descriptions and Specifications
    Table 175. Novartis Recent Developments
    Table 176. Pfizer Corporation Information
    Table 177. Pfizer Description and Major Businesses
    Table 178. Pfizer Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 179. Pfizer Cancer Drug Therapy Product Model Numbers, Pictures, Descriptions and Specifications
    Table 180. Pfizer Recent Developments
    Table 181. Prometheus Labs Corporation Information
    Table 182. Prometheus Labs Description and Major Businesses
    Table 183. Prometheus Labs Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 184. Prometheus Labs Cancer Drug Therapy Product Model Numbers, Pictures, Descriptions and Specifications
    Table 185. Prometheus Labs Recent Developments
    Table 186. Key Raw Materials Lists
    Table 187. Raw Materials Key Suppliers Lists
    Table 188. Cancer Drug Therapy Distributors List
    Table 189. Cancer Drug Therapy Customers List
    Table 190. Cancer Drug Therapy Market Trends
    Table 191. Cancer Drug Therapy Market Drivers
    Table 192. Cancer Drug Therapy Market Challenges
    Table 193. Cancer Drug Therapy Market Restraints
    Table 194. Research Programs/Design for This Report
    Table 195. Key Data Information from Secondary Sources
    Table 196. Key Data Information from Primary Sources
List of Figures
    Figure 1. Cancer Drug Therapy Product Picture
    Figure 3. Global Cancer Drug Therapy Market Share by Type in 2021 & 2028
    Figure 3. Targeted Therapy Product Picture
    Figure 4. Chemotherapy Product Picture
    Figure 5. Immunotherapy Product Picture
    Figure 6. Global Cancer Drug Therapy Market Share by Application in 2021 & 2028
    Figure 7. Angiogenesis Inhibitors
    Figure 8. mTOR Inhibitors
    Figure 9. Monoclonal Antibodies
    Figure 10. Cytokine Immunotherapy (IL-2)
    Figure 11. Cancer Drug Therapy Report Years Considered
    Figure 12. Global Cancer Drug Therapy Sales 2017-2028 (K Units)
    Figure 13. Global Cancer Drug Therapy Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Cancer Drug Therapy Revenue 2017-2028 (US$ Million)
    Figure 15. Global Cancer Drug Therapy Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 16. Global Cancer Drug Therapy Sales Market Share by Region (2017-2022)
    Figure 17. Global Cancer Drug Therapy Sales Market Share by Region (2023-2028)
    Figure 18. North America Cancer Drug Therapy Sales YoY (2017-2028) & (K Units)
    Figure 19. North America Cancer Drug Therapy Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Europe Cancer Drug Therapy Sales YoY (2017-2028) & (K Units)
    Figure 21. Europe Cancer Drug Therapy Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Asia-Pacific Cancer Drug Therapy Sales YoY (2017-2028) & (K Units)
    Figure 23. Asia-Pacific Cancer Drug Therapy Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Latin America Cancer Drug Therapy Sales YoY (2017-2028) & (K Units)
    Figure 25. Latin America Cancer Drug Therapy Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Middle East & Africa Cancer Drug Therapy Sales YoY (2017-2028) & (K Units)
    Figure 27. Middle East & Africa Cancer Drug Therapy Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. The Cancer Drug Therapy Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 29. The Top 5 and 10 Largest Manufacturers of Cancer Drug Therapy in the World: Market Share by Cancer Drug Therapy Revenue in 2021
    Figure 30. Global Cancer Drug Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 31. Global Cancer Drug Therapy Sales Market Share by Type (2017-2028)
    Figure 32. Global Cancer Drug Therapy Revenue Market Share by Type (2017-2028)
    Figure 33. Global Cancer Drug Therapy Sales Market Share by Application (2017-2028)
    Figure 34. Global Cancer Drug Therapy Revenue Market Share by Application (2017-2028)
    Figure 35. North America Cancer Drug Therapy Sales Market Share by Type (2017-2028)
    Figure 36. North America Cancer Drug Therapy Revenue Market Share by Type (2017-2028)
    Figure 37. North America Cancer Drug Therapy Sales Market Share by Application (2017-2028)
    Figure 38. North America Cancer Drug Therapy Revenue Market Share by Application (2017-2028)
    Figure 39. North America Cancer Drug Therapy Sales Share by Country (2017-2028)
    Figure 40. North America Cancer Drug Therapy Revenue Share by Country (2017-2028)
    Figure 41. U.S. Cancer Drug Therapy Revenue (2017-2028) & (US$ Million)
    Figure 42. Canada Cancer Drug Therapy Revenue (2017-2028) & (US$ Million)
    Figure 43. Europe Cancer Drug Therapy Sales Market Share by Type (2017-2028)
    Figure 44. Europe Cancer Drug Therapy Revenue Market Share by Type (2017-2028)
    Figure 45. Europe Cancer Drug Therapy Sales Market Share by Application (2017-2028)
    Figure 46. Europe Cancer Drug Therapy Revenue Market Share by Application (2017-2028)
    Figure 47. Europe Cancer Drug Therapy Sales Share by Country (2017-2028)
    Figure 48. Europe Cancer Drug Therapy Revenue Share by Country (2017-2028)
    Figure 49. Germany Cancer Drug Therapy Revenue (2017-2028) & (US$ Million)
    Figure 50. France Cancer Drug Therapy Revenue (2017-2028) & (US$ Million)
    Figure 51. U.K. Cancer Drug Therapy Revenue (2017-2028) & (US$ Million)
    Figure 52. Italy Cancer Drug Therapy Revenue (2017-2028) & (US$ Million)
    Figure 53. Russia Cancer Drug Therapy Revenue (2017-2028) & (US$ Million)
    Figure 54. Asia Pacific Cancer Drug Therapy Sales Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Cancer Drug Therapy Revenue Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Cancer Drug Therapy Sales Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Cancer Drug Therapy Revenue Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Cancer Drug Therapy Sales Share by Region (2017-2028)
    Figure 59. Asia Pacific Cancer Drug Therapy Revenue Share by Region (2017-2028)
    Figure 60. China Cancer Drug Therapy Revenue (2017-2028) & (US$ Million)
    Figure 61. Japan Cancer Drug Therapy Revenue (2017-2028) & (US$ Million)
    Figure 62. South Korea Cancer Drug Therapy Revenue (2017-2028) & (US$ Million)
    Figure 63. India Cancer Drug Therapy Revenue (2017-2028) & (US$ Million)
    Figure 64. Australia Cancer Drug Therapy Revenue (2017-2028) & (US$ Million)
    Figure 65. Taiwan Cancer Drug Therapy Revenue (2017-2028) & (US$ Million)
    Figure 66. Indonesia Cancer Drug Therapy Revenue (2017-2028) & (US$ Million)
    Figure 67. Thailand Cancer Drug Therapy Revenue (2017-2028) & (US$ Million)
    Figure 68. Malaysia Cancer Drug Therapy Revenue (2017-2028) & (US$ Million)
    Figure 69. Philippines Cancer Drug Therapy Revenue (2017-2028) & (US$ Million)
    Figure 70. Latin America Cancer Drug Therapy Sales Market Share by Type (2017-2028)
    Figure 71. Latin America Cancer Drug Therapy Revenue Market Share by Type (2017-2028)
    Figure 72. Latin America Cancer Drug Therapy Sales Market Share by Application (2017-2028)
    Figure 73. Latin America Cancer Drug Therapy Revenue Market Share by Application (2017-2028)
    Figure 74. Latin America Cancer Drug Therapy Sales Share by Country (2017-2028)
    Figure 75. Latin America Cancer Drug Therapy Revenue Share by Country (2017-2028)
    Figure 76. Mexico Cancer Drug Therapy Revenue (2017-2028) & (US$ Million)
    Figure 77. Brazil Cancer Drug Therapy Revenue (2017-2028) & (US$ Million)
    Figure 78. Argentina Cancer Drug Therapy Revenue (2017-2028) & (US$ Million)
    Figure 79. Middle East and Africa Cancer Drug Therapy Sales Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Cancer Drug Therapy Revenue Market Share by Type (2017-2028)
    Figure 81. Middle East and Africa Cancer Drug Therapy Sales Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Cancer Drug Therapy Revenue Market Share by Application (2017-2028)
    Figure 83. Middle East and Africa Cancer Drug Therapy Sales Share by Country (2017-2028)
    Figure 84. Middle East and Africa Cancer Drug Therapy Revenue Share by Country (2017-2028)
    Figure 85. Turkey Cancer Drug Therapy Revenue (2017-2028) & (US$ Million)
    Figure 86. Saudi Arabia Cancer Drug Therapy Revenue (2017-2028) & (US$ Million)
    Figure 87. UAE Cancer Drug Therapy Revenue (2017-2028) & (US$ Million)
    Figure 88. Cancer Drug Therapy Value Chain
    Figure 89. Cancer Drug Therapy Production Process
    Figure 90. Channels of Distribution
    Figure 91. Distributors Profiles
    Figure 92. Bottom-up and Top-down Approaches for This Report
    Figure 93. Data Triangulation
    Figure 94. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Amgen / Allergan
Argos Therapeutics
AstraZeneca
Aveo Pharmaceuticals
Bayer
Exelixis
Incyte
Merck
Roche
Bristol-Myers Squibb
Eisai
Exelixis
Genentech (Roche)
Novartis
Pfizer
Prometheus Labs
Frequently Asked Questions
Cancer Drug Therapy report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Cancer Drug Therapy report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Cancer Drug Therapy report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Kinase Inhibitors

Kinase Inhibitors market is segmented by players, region (country), by Type and by Application. P ... Read More

Kresoxim Methyl

Kresoxim Methyl market is segmented by Type and by Application. Players, stakeholders, and other  ... Read More

Label Free Detection

Label Free Detection market is segmented by players, region (country), by Type and by Application ... Read More

Lactate Norfloxacin

Lactate Norfloxacin market is segmented by Type and by Application. Players, stakeholders, and ot ... Read More